Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1990-2-22
|
pubmed:abstractText |
In 16 patients with reversible symptoms of cerebrovascular disease a HMPAO- and/or IMP-SPECT was performed. 12 of these patients were suffering from TIA, 4 from PRIND. Using HMPAO-SPECT in 8 out of 9 patients with TIA and in 1 of 2 with PRIND a hypoperfusion could be demonstrated; IMP-SPECT showed a pathological pattern in 3 of 5 patients with TIA and in none of 2 patients with PRIND. A semiquantitative evaluation showed a tracer accumulation reduced by 13 +/- 12% (HMPAO) and 8 +/- 7% (IMP), respectively, in the clinically involved hemisphere, compared to the contralateral side. In circumscript SPECT lesions a reduction by 21 +/- 8% (HMPAO) or 17 +/- 7% (IMP) was observed. The interhemispheric ratio from the HMPAO-SPECT showed a significant correlation to that of the 133Xe-rCBF measurement (r = 0.86; p less than 0.001). SPECT was positive in a higher percentage than TCT, Doppler sonography, radioangiography and 133Xe-rCBF measurement. This does not imply a higher specificity or sensitivity, because a slight inhomogeneous SPECT pattern may occasionally be observed even in normal persons.
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amphetamines,
http://linkedlifedata.com/resource/pubmed/chemical/Iodine Radioisotopes,
http://linkedlifedata.com/resource/pubmed/chemical/Iofetamine,
http://linkedlifedata.com/resource/pubmed/chemical/Organotechnetium Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Oximes,
http://linkedlifedata.com/resource/pubmed/chemical/Technetium Tc 99m Exametazime
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0029-5566
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
221-5
|
pubmed:dateRevised |
2007-1-12
|
pubmed:meshHeading |
pubmed-meshheading:2608445-Adult,
pubmed-meshheading:2608445-Aged,
pubmed-meshheading:2608445-Amphetamines,
pubmed-meshheading:2608445-Brain Ischemia,
pubmed-meshheading:2608445-Cerebrovascular Disorders,
pubmed-meshheading:2608445-Female,
pubmed-meshheading:2608445-Humans,
pubmed-meshheading:2608445-Iodine Radioisotopes,
pubmed-meshheading:2608445-Iofetamine,
pubmed-meshheading:2608445-Ischemic Attack, Transient,
pubmed-meshheading:2608445-Male,
pubmed-meshheading:2608445-Middle Aged,
pubmed-meshheading:2608445-Organotechnetium Compounds,
pubmed-meshheading:2608445-Oximes,
pubmed-meshheading:2608445-Technetium Tc 99m Exametazime,
pubmed-meshheading:2608445-Tomography, Emission-Computed, Single-Photon
|
pubmed:year |
1989
|
pubmed:articleTitle |
[SPECT in reversible symptoms of cerebrovascular diseases].
|
pubmed:affiliation |
Institut für klinische und experimentelle Nuklearmedizin, Universität Bonn, BRD.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract
|